Norinchukin Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Buy |
6,743
+51
| +0.8% | +$10K | 0.01% | 395 |
|
|
2026
Q1 | $1.31M | Sell |
6,692
-36
| -0.5% | -$6.99K | 0.02% | 396 |
|
|
2025
Q4 | $1.17M | Buy |
6,728
+413
| +7% | +$75.2K | 0.01% | 420 |
|
|
2025
Q3 | $1.2M | Buy |
6,315
+133
| +2% | +$23.6K | 0.02% | 402 |
|
|
2025
Q2 | $1.11M | Buy |
6,182
+467
| +8% | +$81.1K | 0.02% | 406 |
|
|
2025
Q1 | $967K | Buy |
5,715
+753
| +15% | +$124K | 0.02% | 394 |
|
|
2024
Q4 | $749K | Buy |
4,962
+412
| +9% | +$64.1K | 0.02% | 418 |
|
|
2024
Q3 | $706K | Buy |
4,550
+624
| +16% | +$93.2K | 0.02% | 411 |
|
|
2024
Q2 | $537K | Buy |
3,926
+87
| +2% | +$11.9K | 0.02% | 421 |
|
|
2024
Q1 | $511K | Sell |
3,839
-96
| -2% | -$12.5K | 0.02% | 440 |
|
|
2023
Q4 | $543K | Sell |
3,935
-361
| -8% | -$47.5K | 0.01% | 419 |
|
|
2023
Q3 | $524K | Sell |
4,296
-4,581
| -52% | -$610K | 0.01% | 419 |
|
|
2023
Q2 | $1.25M | Buy |
8,877
+1,567
| +21% | +$216K | 0.02% | 383 |
|
|
2023
Q1 | $1.03M | Buy |
7,310
+88
| +1% | +$12.6K | 0.02% | 367 |
|
|
2022
Q4 | $1.13M | Sell |
7,222
-1,955
| -21% | -$281K | 0.02% | 336 |
|
|
2022
Q3 | $1.13M | Buy |
9,177
+1,050
| +13% | +$138K | 0.02% | 356 |
|
|
2022
Q2 | $1.08M | Sell |
8,127
-2,930
| -26% | -$399K | 0.02% | 354 |
|
|
2022
Q1 | $1.51M | Buy |
11,057
+512
| +5% | +$71.4K | 0.02% | 378 |
|
|
2021
Q4 | $1.82M | Sell |
10,545
-50
| -0.5% | -$7.61K | 0.02% | 331 |
|
|
2021
Q3 | $1.54M | Sell |
10,595
-214
| -2% | -$31.3K | 0.02% | 354 |
|
|
2021
Q2 | $1.43M | Sell |
10,809
-293
| -3% | -$38.4K | 0.02% | 364 |
|
|
2021
Q1 | $1.43M | Buy |
11,102
+71
| +0.6% | +$8.75K | 0.02% | 350 |
|
|
2020
Q4 | $1.31M | Sell |
11,031
-915
| -8% | -$112K | 0.02% | 334 |
|
|
2020
Q3 | $1.37M | Sell |
11,946
-292
| -2% | -$34.5K | 0.02% | 302 |
|
|
2020
Q2 | $1.4M | Sell |
12,238
-174
| -1% | -$18.5K | 0.02% | 282 |
|
|
2020
Q1 | $997K | Sell |
12,412
-6,265
| -34% | -$649K | 0.02% | 314 |
|
|
2019
Q4 | $2M | Sell |
18,677
-1,610
| -8% | -$168K | 0.03% | 326 |
|
|
2019
Q3 | $2.17M | Buy |
20,287
+348
| +2% | +$35.7K | 0.03% | 318 |
|
|
2019
Q2 | $2.03M | Sell |
19,939
-6,552
| -25% | -$630K | 0.03% | 328 |
|
|
2019
Q1 | $2.38M | Buy |
26,491
+632
| +2% | +$54.8K | 0.03% | 348 |
|
|
2018
Q4 | $2.15M | Buy |
25,859
+7,470
| +41% | +$700K | 0.03% | 330 |
|
|
2018
Q3 | $1.98M | Buy |
18,389
+2,110
| +13% | +$231K | 0.03% | 319 |
|
|
2018
Q2 | $1.79M | Buy |
16,279
+2,901
| +22% | +$302K | 0.03% | 309 |
|
|
2018
Q1 | $1.34M | Buy |
13,378
+2,000
| +18% | +$205K | 0.02% | 334 |
|
|
2017
Q4 | $1.12M | Sell |
11,378
-15,708
| -58% | -$1.49M | 0.02% | 366 |
|
|
2017
Q3 | $2.54M | Buy |
27,086
+549
| +2% | +$58.3K | 0.05% | 214 |
|
|
2017
Q2 | $2.95M | Sell |
26,537
-134
| -0.5% | -$14.2K | 0.06% | 171 |
|
|
2017
Q1 | $2.62M | Buy |
26,671
+18,260
| +217% | +$1.74M | 0.06% | 176 |
|
|
2016
Q4 | $773K | Buy |
8,411
+968
| +13% | +$83.4K | 0.02% | 379 |
|
|
2016
Q3 | $630K | Buy |
7,443
+23
| +0.3% | +$1.93K | 0.02% | 398 |
|
|
2016
Q2 | $604K | Buy |
7,420
+92
| +1% | +$7.01K | 0.01% | 394 |
|
|
2016
Q1 | $524K | Buy |
7,328
+630
| +9% | +$42.3K | 0.01% | 415 |
|
|
2015
Q4 | $476K | Sell |
6,698
-1,514
| -18% | -$102K | 0.01% | 405 |
|
|
2015
Q3 | $505K | Buy |
8,212
+81
| +1% | +$5.66K | 0.01% | 431 |
|
|
2015
Q2 | $590K | Sell |
8,131
-424
| -5% | -$31.3K | 0.02% | 410 |
|
|
2015
Q1 | $657K | Buy |
8,555
+38
| +0.4% | +$2.72K | 0.02% | 408 |
|
|
2014
Q4 | $571K | Sell |
8,517
-913
| -10% | -$57.6K | 0.01% | 422 |
|
|
2014
Q3 | $572K | Buy |
9,430
+4,038
| +75% | +$249K | 0.02% | 311 |
|
|
2014
Q2 | $316K | Sell |
5,392
-579
| -10% | -$33.9K | 0.01% | 396 |
|
|
2014
Q1 | $346K | Buy |
5,971
+539
| +10% | +$28.9K | 0.01% | 397 |
|
|
2013
Q4 | $291K | Sell |
5,432
-272
| -5% | -$16.1K | 0.01% | 400 |
|
|
2013
Q3 | $352K | Buy |
5,704
+231
| +4% | +$13.8K | 0.01% | 349 |
|
|
2013
Q2 | $332K | Buy |
+5,473
| New | +$326K | 0.01% | 332 |
|
Other funds holding DGX
EIG
Norinchukin Bank's DGX Position: Q2 2026 in Review
Norinchukin Bank increased its Quest Diagnostics (DGX) stake by 0.76% in Q2 2026, buying an estimated $10K and bringing the position to 6,743 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #395.
Norinchukin Bank first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.95M in Q2 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Norinchukin Bank held 6,743 shares of Quest Diagnostics worth $1.43M as of Q2 2026.
- Norinchukin Bank bought 51 Quest Diagnostics shares in Q2 2026, an estimated $10K.
- Quest Diagnostics made up 0.01% of Norinchukin Bank's portfolio in Q2 2026, its #395 holding.
- Norinchukin Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- Norinchukin Bank's Quest Diagnostics position peaked at $2.95M in Q2 2017.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.